Organization

Leeds Teaching Hospital, Leeds, United Kingdom

1 abstract

Abstract
BIOLOGIC FREE DISEASE CONTROL (BFDC) IN EARLY RA: PREDICTORS OF SUCCESSFUL WITHDRAWAL OF ADALIMUMAB (ADA) AFTER ACHIEVING STABLE LOW DISEASE ACTIVITY WITH ADA PLUS METHOTREXATE (MTX) – DATA FROM THE OPTIMA STUDY
Org: Medical Univ of Vienna, Vienna, Austria, Leeds Teaching Hospital, Leeds, United Kingdom, U of Texas Southwestern Med Center, Dallas, United States, Karolinska Univ Hospital, Stockholm, Sweden, Abbott, Abbott Park, United States,